The FDA accepted Bayer's sNDA and granted Priority Review to elinzanetant for vasomotor symptoms in women on endocrine therapy for HR+ breast cancer.
|Articles|September 1, 2007
"Mommy Mouth-to-Mouth" Removes Nasal Foreign Bodies
Removing foreign objects from a toddler's nose is usually a challenge, since the child typically refuses to let the clinician get close enough to attempt extraction.
Advertisement
Removing foreign objects from a toddler's nose is usually a challenge, since the child typically refuses to let the clinician get close enough to attempt extraction. A method that I have found successful for objects fairly distal in the nasal passage is to have the child's mother perform a "mouth-to-mouth" maneuver, gently blowing air into her son's or daughter's oropharynx. This often provides enough pressure to dislodge the object from the nostril without terrorizing the child with the approach of an unfamiliar face.
-- Andrea Hillerud, MD
Eau Claire, Wis
Advertisement
Related to this article
The FDA has approved baricitinib for adolescents aged 12 and older with severe alopecia areata, marking the first systemic oral therapy cleared for this population.
Stroke incidence in adults aged 20–54 nearly doubled from 1993–1994 to 2020, driven largely by ischemic stroke, while 30-day fatality declined, according to new research.
The FDA has approved insulin efsitora alfa-gobe (Onswik) for adults with type 2 diabetes.
New research links type 2 diabetes and genetic risk to MASLD cirrhosis before 50, warning age-based fibrosis scores can miss severe disease.
FDA updates sotatercept-csrk label with HYPERION data, showing earlier use cuts PAH clinical worsening risk 76% alongside background therapy.
A US laboratory study found that 29.5% of patients with Lyme antibodies were seropositive for at least 1 other tick-borne pathogen.
Lumateperone reduced acute mania symptoms by day 3 in a phase 3 bipolar 1 trial, according to Johnson & Johnson.
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Expands Baricitinib Approval to Adolescents With Severe Alopecia Areata
2
Detecting Atrial Fibrillation in Primary Care: Warning Signs and Modifiable Risk Factors
3
Safety, Dosing, and Drug Interactions for Dextromethorphan-Bupropion in Agitation
4
Beyond Semaglutide and Tirzepatide: The Next Wave of Obesity Medicines
5